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Abstract The effect of Ca2+ on inositol (1,4,5)-trisphosphate 3-
kinase (3-kinase) activity was measured on Xenopus oocyte
cytosolic extracts. The Ca2+-evoked elevation in 3-kinase
activity appeared to be mediated by calmodulin (CaM) and the
calmodulin-dependent protein kinase II (CaMKII). The results
observed in vitro were totally retrieved in intact oocytes and tend
to demonstrate the involvement of a CaMKII-mediated phos-
phorylation in the regulation of 3-kinase activity. Finally,
electrophysiological recordings of InsP3-elicited chloride current
transients in the presence of CaM/CaMKII inhibitors allowed to
postulate an involvement of 3-kinase activity in the regulation of
InsP3-mediated Ca2+ release.
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1. Introduction
Inositol (1,4,5)-trisphosphate (InsP3) is a well established
second messenger that binds to the InsP3 receptor to release
Ca2 from intracellular stores [1]. In many tissues, cytoplas-
mic Ca2 concentration modulate InsP3-mediated Ca2 re-
lease (IMCR) in a biphasic manner. At submicromolar con-
centrations, Ca2 activates the release process whereas at
higher concentrations Ca2 is inhibitory. This biphasic e¡ect
has been described in Xenopus oocytes [2], smooth muscle [3],
brain [4] and hepatocytes [5]. Most of the studies concerning
IMCR were focused on the release mechanism and more pre-
cisely on the InsP3 receptor itself. Ca2 can activate and in-
hibit IMCR either directly by interacting with an activatory or
inhibitory site on the receptor or indirectly through activation
or inhibition of the regulating enzymes including InsP3 me-
tabolizing enzymes. The crucial parameters that regulate the
formation and termination of the Ca2 signals are the gener-
ation and the degradation of the second messenger. Two pri-
mary degradative pathways exist for InsP3 but they di¡er in
their relative importance among cell types (for review, see [6]).
Several isoforms of the InsP3 5-phosphatase (5-phosphatase)
dephosphorylate InsP3 yielding Ins(1,4)P2 (InsP2). InsP3 is
also a substrate for the 3-kinase which phosphorylates InsP3
to form Ins(1,3,4,5)P4 (InsP4). This confers a dual role to the
3-kinase in generating another second messenger as well as
decreasing the InsP3 concentration. In rat brain, the 3-kinase
has been demonstrated to be activated by cytosolic free Ca2
([Ca2]i) through CaM activation [7]. Moreover, Communi et
al. [8] demonstrated that a CaMKII-mediated phosphoryla-
tion of the rat brain 3-kinase is responsible for the agonist-
mediated activation of the enzyme. The conclusions drawn by
these latter reports allow to postulate an involvement of the
InsP3 metabolism in the Ca2-dependent regulation of IMCR.
In the present report, we ¢rst investigated the e¡ects of
Ca2, CaM and CaM/CaMKII inhibitors on the 3-kinase ac-
tivity of Xenopus oocytes extracts. Our results demonstrated
that the Ca2-evoked positive regulation of 3-kinase depends
on CaM either directly or indirectly through a CaMKII-medi-
ated phosphorylation. The e¡ects found with the extracts were
consistently retrieved in vivo by the measurement of InsP3
degradation in intact oocytes. Finally, electrophysiological
data led to the conclusion that an activation of the 3-kinase
may be involved in the Ca2-dependent down regulation of
IMCR.
2. Materials and methods
Adult Xenopus laevis were anaesthetized in tricaine methane sulpho-
nate (0.2%; MS 222). Pieces of ovary were surgically removed and
placed in ND96 medium of the following composition (mM): NaCl,
96; CaCl2, 1.8; KCl, 2; MgCl2, 2; HEPES, 5, titrated to pH 7.4 with
NaOH. Oocytes were treated for 2^3 h with collagenase (2 mg/ml) in
Ca2-free medium in order to remove follicular cells. Stage V and VI
oocytes were selected and maintained in ND96 supplemented with
gentamycin (50 Wg/ml) at 20‡C for up to 5 days. The medium was
renewed daily.
The procedure for measurement of 3-kinase activity in cytoplasmic
extracts was adapted from [9]. Oocytes were homogenized in 200 Wl
ice cold bu¡er M (100 mM KCl, 1 mM MgCl2, 10 mM HEPES pH
7.0 with KOH, 50 mM sucrose, 10 Wg/ml cytochalasin B, 0.4 mM
phenylmethanesulfonyl£uoride, 5 WM leupeptin, 20 mM benzamidine,
10 Wg/ml calpain inhibitor) using a te£on homogenizer. The crude
soluble fraction was obtained by centrifugation at 35 000Ug for 60
min. A 40 Wl portion of a further bu¡er was added to 60 Wl of crude
soluble fraction to give a concentration of 84 mM HEPES/NaOH, pH
7.5, 1 mg/ml of bovine serum albumin, 1 mM ATP, 20 mM MgCl2,
2.5 mM 2,3-bisphosphoglycerate, 1 mM EGTA, 1 WM InsP3 and 2000
cpm of [3H]-InsP3 (speci¢c activity: 40 Ci/mmol; Amersham, UK).
Ca2 was added to adjust the free Ca2 concentration calculated using
an apparent a⁄nity constant of EGTA for calcium of 3.17U106 M31
at pH 7.5 and Ca2/CaM was added when needed. After 8 min in-
cubation at 37‡C, 1 ml of ice cold 0.1 M formic acid/0.4 M ammo-
nium formate was added to stop the reaction. Samples were diluted
with an equal volume of 0.1 M formic acid/0.4 M ammonium formate
prior to loading on to a 0.6 ml Dowex 1U8 (formate form; Bio-Rad)
column. The column was washed with 6 ml of 0.1 M formic acid/0.4 M
ammonium formate. To elute InsP3, 20 ml of 0.1 M formic acid/0.7 M
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ammonium formate were applied to the column and, for elution of
InsP4, 8 ml of 0.1 M formic acid/1.2 M ammonium formate were
applied. Radioactivity was determined by liquid scintillation counting.
Enzyme activity was expressed as nmoles of InsP4 produced/min/mg
protein. Protein was determined using a Bradford assay (Bio-Rad). In
all experiments, enzyme activity was assayed at 1 WM InsP3.
For the measurements of InsP3 degradation in intact oocytes, the
cells were microinjected with 10 nl of a solution containing 0.1 WCi of
lyophilized [3H]-InsP3 (40 Ci/mmol; Amersham) mixed with 1 Wl of
cold InsP3 (9.75U1035 M). Total calculated concentration of InsP3
(cold and 3H labeled) in the injection pipette was 0.1 mM. Given an
injection volume of V10 nl and an oocyte volume of 1 Wl the calcu-
lated intracellular concentration was V1 WM. The exact volume of
injectate was determined from the total number of counts contained
into the oocyte. The oocytes were incubated at room temperature for
the indicated times. At the end of the incubation period, the medium
surrounding the oocyte was removed to determine how much of the
3H label has leaked from the oocyte. Cells that lost greater than 10%
of the label were excluded. InsP metabolism was arrested by crushing
the oocyte in 1 ml of ice cold bu¡er containing 0.1 M formic acid/0.4
M ammonium formate. The soluble fraction obtained by centrifuga-
tion at 35 000Ug for 10 min was loaded on to a 0.6 ml Dowex 1U8
(formate form; Bio-Rad) column. The chromatography was carried
out as described above.
Changes in [Ca2]i were monitored by electrophysiological record-
ing of the Ca2-activated Cl3 current (IClCa) as described elsewhere
[10]. Brie£y, oocytes were impaled by two microelectrodes ¢lled with
3 M KCl (0.5^1 M6) and voltage-clamped to 380 mV using a Gene-
clamp 500 ampli¢er (Axon Instruments). Data acquisition and anal-
ysis were conducted using the pClamp software package (Axon In-
struments). Experiments were carried out at room temperature (18^
22‡C). Microinjections were performed with a micropipette which tip
diameter did not exceed 10 Wm.
All chemicals were purchased from Sigma unless otherwise stated.
Calmodulin was from Calbiochem.
3. Results and discussion
In a ¢rst series of experiments, the 3-kinase activity of the
soluble fraction of Xenopus oocytes homogenates was meas-
ured in the absence of Ca2, in the presence of Ca2 and in
the presence of Ca2 and CaM. Kinase activities measured in
the presence of EGTA (control) were always lower as com-
pared to the level reached in the presence of Ca2 (Fig. 1). In
the presence of Ca2, kinase activities were potentiated by
addition of CaM (Fig. 1A). Conversely, the presence of the
speci¢c CaM antagonist peptide RS20 [11,12] prevented the
Ca2- and Ca2/CaM-mediated e¡ects on the 3-kinase activ-
ity. These results con¢rm those obtained in rat brain by [7]
and are in agreement with [13,14] who guessed that the Ca2
sensitivity of the 3-kinase of Xenopus oocyte was mediated by
CaM. Moreover, it has been recently reported that phospho-
rylation of the rat brain 3-kinase A by CaMKII results in 8- to
10-fold enzyme activation and a 25-fold increase in its sensi-
tivity to the Ca2/CaM complex [8]. Addition of the potent
CaMKII inhibitors KN-62 and KN-93 to the extracts pre-
vented the Ca2/CaM-mediated activation of the 3-kinase
(Fig. 1B). The same e¡ects were obtained by microinjecting
the highly speci¢c CaMKII inhibitory peptide CaMKII(290^
309) prior to cytoplasm extraction. These results allowed us to
postulate an involvement of a CaMKII-mediated phospho-
rylation of the 3-kinase in its own regulation. The involvement
of a phosphorylation is further corroborated by the fact that a
preincubation of the oocytes with the well known phosphatase
inhibitor okadaic acid provided a maximal activation of the 3-
kinase (Fig. 1B). A recent report concerning the metabolism
of InsP3 and InsP4 in Xenopus oocytes [14] led us to think that
an alteration in the metabolism of InsP3 may account in the
regulation of IMCR. Measurements of InsP3 degradation in
intact oocytes were conducted to investigate the physiological
relevance of the Ca2/CaM-dependency of the 3-kinase. In
that purpose, single oocytes were injected with [3H]-InsP3 to
determine its immediate metabolism. The chromatographic
method employed in this study (Fig. 2A) allowed the separa-
tion of InsP92, InsP3 and InsP4. For experimental time points
of 5 min or less, the reactions of InsP3 are segregated into two
distinct pathways without common metabolites [13,14]. In the
3-kinase pathway, InsP4 accumulates with very little conver-
sion to the lower inositol phosphates and was used as an
estimate for the 3-kinase activity. On the other hand, the
sum of the concentrations of the products of the 5-phospha-
tase pathway (InsP92) was used to estimate the activity of the
5-phosphatase toward InsP3. Our results con¢rmed that in
vivo, InsP3 is predominantly metabolized by the 3-kinase
whereas in the same conditions, InsP92 does not accrue to a
substantial degree. The measurement of InsP3 degradation has
then been carried out on oocytes that had been injected either
with Ca2/CaM or RS20 prior to InsP3 stimulation. Fig. 2Ba
shows that an accrued amount of Ca2/CaM caused an accel-
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Fig. 1. Regulation of 3-kinase activity in Xenopus oocytes cytosolic
extracts. The number of cells for each condition is indicated be-
tween brackets. Results are presented as activity þ S.E. (indicated by
bars). A: The assays were performed in the absence of Ca2, 10
WM free Ca2 and 10 WM free Ca2 supplemented with 1 WM CaM
as indicated on the x-axis. The same experiments were performed in
the presence of 5 WM of RS20 as indicated. B: All assays were per-
formed in the presence of 10 WM free Ca2 supplemented with 1 WM
CaM. The x-axis indicates the reagents that were added to the mix-
ture. KN-62, KN-93 and CaMKII(290^309) were used at 1 WM;
okadaic acid was used at 30 nM.
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eration of InsP4 formation. On the contrary, this formation
was clearly slowed down in the presence of the CaM antago-
nist RS20. These modulations of InsP3 degradation appeared
to entirely rely on the 3-kinase activity (Fig. 2Ba) whereas the
5-phosphatase activity was not a¡ected by any reagent (Fig.
2Bb). Finally, the data presented on Fig. 2C show that InsP4
formation is de¢nitely a¡ected by an intracellular treatment
with KN-93 or CaMKII(290^309). The in vitro experiments
indicated that in the presence of RS20 or any CaMKII antag-
onist, Ca2 and Ca2/CaM failed to cause an increase in 3-
kinase activity. The InsP4 formation measured in vivo in the
presence of CaM/CaMKII antagonists seems to result from 3-
kinase basal activity. In the absence of inhibitor, the observed
elevation of InsP4 formation is liable to be mediated by an
increase in 3-kinase activity due to InsP3-evoked elevation in
[Ca]i, this e¡ect being further reinforced by addition of Ca2/
CaM. At the light of the experiments conducted with CaMKII
inhibitors, it seems likely that CaMKII phosphorylates the 3-
kinase resulting in an increase in enzymatic activity as re-
ported for rat brain [8]. In order to assess the involvement
of 3-kinase in IMCR, electrophysiological experiments were
performed on oocytes that had been pre-injected with either
Ca2/CaM or RS20. Injection of InsP3 gave rise to typical
inward Cl3 current transients on oocytes voltage-clamped at
380 mV. Pre-injection of the oocytes with Ca2/CaM signi¢-
cantly reduced the amplitude of InsP3-evoked Cl3 current
transients (413 þ 44 nA, n = 14 vs. 699 þ 40 nA, n = 21; Fig.
3A, traces b and a). Inversely, intracellular pre-injection of
RS20 led to a net increase in the amplitude of the current
(1020 þ 137 nA, n = 9 vs. 699 þ 40 nA, n = 21; Fig. 3A, traces
c and a). Alternatively, oocytes were stimulated by the phos-
pholipase C (PLC)-linked agonist lysophosphatidic acid
(LPA) which interacts with speci¢c receptors at the plasma
membrane of Xenopus oocytes [15]. Fig. 3B shows that the
response to LPA is partially inhibited by Ca2/CaM injection
(310 þ 62 nA, n = 7 vs. 829 þ 112 nA, n = 7; Fig. 3B, traces b
and a) and greatly potentiated by RS20 treatment (1787 þ 328
nA, n = 8 vs. 829 þ 112 nA, n = 7; Fig. 3B, traces c and a).
Injection of InsP3 into the oocytes or PLC stimulation cause a
biphasic increase in [Ca]i : the initial transient phase represents
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Fig. 2. Measurement of InsP3 metabolism in intact oocytes. Radio-
activity speci¢c to each InsP was expressed as a percentage of total
injected dpm. Data were averaged from eight cells for each point.
A: The schematic of InsP3 metabolism is valid for incubation times
of 5 min. Value recorded at each time point represented mean þ S.E.
of radioactivity attributable to each InsP as indicated in the inset.
B: Ca2/CaM (Ca2 2 WM/CaM 1 WM ¢nal estimated concen-
tration) and RS20 (5 WM ¢nal concentration) modulate 3-kinase
activity but do not a¡ect 5-phosphatase. a: InsP4 formation is
measured as a function of time in control conditions or in the pres-
ence of CaM or RS20 as indicated in the inset. b: No modulation
of InsP92 formation could be elicited by either CaM or RS20 (see
inset) when injected into the oocytes. C: Experiments identical to
those described in B were performed with CaMKII speci¢c inhibi-
tors (used compound indicated in inset; their ¢nal intraoocyte con-
centration was 1 WM). InsP4 formation appears to be clearly dimin-
ished by CaMKII inhibitors.
Fig. 3. E¡ects of Ca2/CaM complex or RS20 microinjection on
IClCa transients elicited by either InsP3 injection or LPA superfu-
sion. Xenopus oocytes were voltage-clamped at 380 mV and bathed
in ND96 medium. A: The oocytes were injected with InsP3 (1 WM,
¢nal concentration, S). Pretreatment of the oocytes with Ca2/CaM
(Ca2 2 WM/CaM 1 WM) reduced the amplitude of the InsP3-evoked
Cl3 current transient whereas it was potentiated by RS20 (5 WM, ¢-
nal concentration) pre-injection. B: The same results were obtained
when the Cl3 current transient was triggered by LPA superfusion (1
WM, 30 s, black box).
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the release of Ca2 from intracellular stores and the more
sustained phase that follows is referred to as capacitative
Ca2 entry [16]. The presence of an accrued amount of
Ca2/CaM into the oocytes caused an important reduction
of the amplitude of both phases of [Ca]i increase whereas
the opposite e¡ect was observed with RS20. To further estab-
lish the link between 3-kinase activity and IMCR, we directly
compared the maximal amplitude of the ¢rst phase of the
current elicited by InsP3 injection into Ca2/CaM-, RS20-,
KN-93- and CaMKII(290^309)-treated oocytes to its corre-
sponding 3-kinase activity. Results summarized in Table 1
show a de¢nitive correlation between the current amplitude
and the 3-kinase activity. Basically, the current reaches its
maximal amplitude (146% of control) for the lowest value
of 3-kinase activity (53% of control) which was elicited by
microinjection of CaMKII inhibitory peptide into the oocyte
(Table 1). It seems therefore likely that the level of 3-kinase
activity directly regulates the amount of InsP3 and conse-
quently modulates the amplitude of the Ca2 release process.
Furthermore, our data tend to indicate that the 3-kinase acti-
vation process in Xenopus oocytes may arise from its phos-
phorylation by CaMKII. It has been reported that IMCR is
activated by CaMKII in a Ca2-dependent manner and in-
hibited by phosphatase 2B [17]. In this context, IMCR should
have been enhanced by Ca2/CaM and instead it was inhib-
ited. The same paradox was raised by the CaM/CaMKII in-
hibitors which caused an increase in the release process
although they should have been inhibitory. These data led
us to put forward the proposal that the modulation of
IMCR we observed may arise from InsP3 metabolism through
3-kinase activation or inhibition. An increase in 3-kinase ac-
tivity could be responsible for a signi¢cant reduction of InsP3
concentration. Conversely, inhibiting the CaM/CaMKII path-
way would prevent any Ca2-evoked increase in 3-kinase ac-
tivity resulting in a higher InsP3 concentration as compared to
control conditions. This interpretation is corroborated by the
fact that the e¡ects of both CaM and inhibitors are already
perceptible at the mean time of appearance of the peak inward
current (10^15 s). Because of the use of a permeabilized cell
system on which InsP3 was added extracellularly, it is possible
that Zhang et al. [17] did not observe the e¡ects of InsP3
metabolism. One may reasonably propose that the 3-kinase
of Xenopus oocytes could be regulated by the Ca2/CaM com-
plex either directly or indirectly through a CaMKII-mediated
phosphorylation. The fact that the e¡ects of CaM and CaM/
CaMKII inhibitors on IMCR could be elicited using a phys-
iological way to produce InsP3 tend to demonstrate that the 3-
kinase may play a key role in regulating signals arising from
the PLC-related transduction system. Finally, as theoretically
supposed by [18] the regulation of 3-kinase by Ca2 through
CaM might represent an additional pathway to support the
Ca2-mediated down regulation of IMCR.
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Table 1
Comparison of Cl3 current transients amplitude and 3-kinase activity elicited by InsP3 injection in control and CaM/CaMKII inhibitors in-
jected oocytes
Condition Imax Activity (15 s)
(nA) % of control nmol/min/mg % of control
Control 699 þ 40 100 0.93 þ 0.09 100
RS20 950 þ 73 136 0.63 þ 0.07 68
KN-93 998 þ 140 143 0.55 þ 0.05 59
CaMKII(290^309) 1020 þ 137 146 0.49 þ 0.05 53
Voltage-clamped Xenopus oocytes were injected with InsP3 (1 WM ¢nal intraoocyte concentration) and the maximal amplitude of the ¢rst phase of
the response was considered as an indicator of the Ca2 release magnitude. Values are expressed as current amplitude and percentage of control.
The 3-kinase activity measured 15 s after InsP3 injection is reported in the table in control conditions as well as in the presence of RS20 (5 WM),
KN-93 (1 WM) or CaMKII(290^309) (1 WM). Values are indicated as enzyme activity and percentage of control.
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